ストックスクリーナーアプリを入手
33.78
9.00%
2.79
前日終値:
$30.99
開ける：
$34.305
24時間の取引高:
2.04M
Relative Volume:
2.54
時価総額：
$3.68B
収益：
$355.75M
当期純損益:
$-270.85M
株価収益率:
-12.51
EPS:
-2.7
ネットキャッシュフロー:
$-218.63M
1週間 パフォーマンス:
+16.48%
1か月 パフォーマンス:
+29.92%
6か月 パフォーマンス:
+93.03%
1年 パフォーマンス:
+69.66%
1日の値動き範囲:
$33.36
$35.00
1週間の範囲:
$30.55
$35.00
52週間の値動き範囲:
$13.48
$36.60
Zai Lab Limited Adr Stock (ZLAB) Company Profile
ZLAB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ZLAB
Zai Lab Limited Adr
|
33.78 | 3.68B | 355.75M | -270.85M | -218.63M | -2.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Zai Lab Limited Adr Stock (ZLAB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-12-14 | 開始されました | Morgan Stanley | Overweight |
| 2023-08-10 | 開始されました | Cantor Fitzgerald | Overweight |
| 2022-01-21 | 開始されました | Macquarie | Outperform |
| 2021-10-12 | 開始されました | Bernstein | Mkt Perform |
| 2020-04-28 | 開始されました | Goldman | Buy |
| 2020-04-15 | 開始されました | Guggenheim | Buy |
| 2019-07-12 | 開始されました | BofA/Merrill | Buy |
| 2019-07-05 | 開始されました | Macquarie | Outperform |
| 2019-01-29 | 開始されました | Credit Suisse | Outperform |
| 2018-11-21 | 開始されました | Jefferies | Buy |
| 2018-06-21 | 再開されました | Leerink Partners | Outperform |
| 2018-02-14 | アップグレード | JP Morgan | Neutral → Overweight |
| 2017-10-16 | 開始されました | JP Morgan | Neutral |
| 2017-10-16 | 開始されました | Leerink Partners | Outperform |
すべてを表示
Zai Lab Limited Adr (ZLAB) 最新ニュース
Financial Snapshot: Analyzing Zai Lab Limited ADR (ZLAB)’s Key Ratio Metrics - The Dwinnex
Watsco Posts Upbeat Results, Joins GeneDx, Intel And Other Big Stocks Moving Higher On Tuesday - Benzinga
With 73% ownership in Zai Lab Limited (NASDAQ:ZLAB), institutional investors have a lot riding on the business - Yahoo Finance
Zai Lab Limited (NASDAQ:ZLAB) Short Interest Up 27.4% in January - Defense World
Sidley Advised Zai Lab on its Offering of ADSs and Issuance of Underlying Shares - Legal Desire News Network
Analysts Set Expectations for Zai Lab FY2024 Earnings - Defense World
Zai Lab (NASDAQ:ZLAB) Stock Rating Upgraded by Cantor Fitzgerald - Defense World
Forge Global Holdings Inc (FRGE)’s stock chart: A technical perspective - US Post News
Perimeter Solutions Inc (PRM)’s stock price in review: A technical analysis - US Post News
Was anything positive for Zai Lab Limited ADR (ZLAB) stock last session? - US Post News
United Natural Foods Inc (UNFI)’s stock performance: a year in review - US Post News
A stock that deserves closer examination: Cybin Inc (CYBN) - US Post News
Market Highlights: Zai Lab Limited ADR (ZLAB) Ends on a Low Note at 26.77 - The Dwinnex
Daily Progress: Concentrix Corp (CNXC) Drop -0.89, Closing at 48.99 - The Dwinnex
Market Watch: Rekor Systems Inc (REKR)’s Noteworthy Gain, Closing at 2.20 - The Dwinnex
Closing Strong: Selective Insurance Group Inc (SIGI) Ends at 83.49, Up 0.87 from Last Close - The Dwinnex
ZLAB (Zai Lab Limited ADR) may reap gains as insiders became active recently - Knox Daily
Zai Lab Limited ADR (ZLAB) looking to reclaim success with recent performance - SETE News
19,502 Shares in Zai Lab Limited (NASDAQ:ZLAB) Purchased by SG Americas Securities LLC - MarketBeat
SG Americas Securities LLC Makes New $511,000 Investment in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Wall Street Analysts Believe Zai Lab Limited (ZLAB) Could Rally 95.6%: Here's is How to Trade - Yahoo Finance
Zai Lab to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Recent Corporate Updates on February 27, 2025 - Business Wire
FDA gives Zai Lab’s small cell lung cancer therapeutic orphan drug designation - Mugglehead
Cantor Fitzgerald Comments on Zai Lab FY2025 Earnings - Defense World
Zai Lab Receives Orphan Drug Designation from the U.S. FDA for ZL-1310 (DLL3 ADC) for the Treatment of Small Cell Lung Cancer (SCLC) - Yahoo Finance
Here’s Why Analysts Are Bullish on Zai Lab Limited (ZLAB) - Insider Monkey
Zai Lab Limited (NASDAQ:ZLAB) Position Decreased by JPMorgan Chase & Co. - Defense World
Schrodinger Inc (NASDAQ: SDGR) Up 1.66%: This Is What Analysts Are Now Forecasting - Stocks Register
Zai Lab Announces Acceptance of New Drug Application for KarXT for the Treatment of Schizophrenia - Business Wire
Hennion & Walsh Asset Management Inc. Has $4.80 Million Position in Zai Lab Limited (NASDAQ:ZLAB) - MarketBeat
Sage Therapeutics (SAGE) Moves 35.1% Higher: Will This Strength Last? - Yahoo Finance
Vertex Pharmaceuticals Incorporated and Zai Lab Limited Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan Region and Singapore - Marketscreener.com
Geode Capital Management LLC Boosts Stock Position in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Vertex and Zai Lab Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan Region and Singapore - Business Wire
Zai Lab Announces Strategic Partnership with MediLink Therapeutics to Develop a Novel LRRC15 Antibody-Drug Conjugate - Business Wire
Zai Lab Secures Debt Facility to Bolster Financial Standing - TipRanks
Rafael Amado Sells 7,583 Shares of Zai Lab Limited (NASDAQ:ZLAB) Stock - MarketBeat
Zai Lab Limited (NASDAQ:ZLAB) Shares Sold by State Street Corp - Defense World
Zai Lab (NASDAQ:ZLAB) Shares Gap Down – What’s Next? - Defense World
Zai Lab Limited (ZLAB) Upgraded to Buy: What Does It Mean for the Stock? - MSN
BNP Paribas Financial Markets Has $31,000 Stock Position in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Zai Lab Announces Participation in Investor Conference in January 2025 - Business Wire
Janus Henderson Group PLC Increases Stock Holdings in Zai Lab Limited (NASDAQ:ZLAB) - MarketBeat
Zai Lab Limited ADR (NASDAQ: ZLAB) Could Pass $101 In One Year Stock Forecast - Stocks Register
Bamco Inc. NY Increases Stake in Zai Lab Limited (NASDAQ:ZLAB) - MarketBeat
Stocks to Watch Monday: Stellantis, Tesla, Intel, Super Micro - The Wall Street Journal
Zai Lab and Novocure Announce Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer - Business Wire
Daiwa Securities Group Inc. Purchases 9,364 Shares of Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Algert Global LLC Makes New Investment in Zai Lab Limited (NASDAQ:ZLAB) - MarketBeat
(repotrectinib) for ROS1+ NSCLC and Other Updates in China’s National Reimbursement Drug List - Business Wire
The week in pharma: action, reaction and insight – week to November 22 - The Pharma Letter
Zai Lab Limited Adr (ZLAB) 財務データ
収益
当期純利益
現金流量
EPS
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):